by healthadvances Posted on May 18, 2023 The Woes and Wins of CAR-T Manufacturing: Lessons from Abecma and Carvykti Read More
by healthadvances Posted on May 17, 2023 Impact of the Institute for Clinical and Economic Review (ICER) on Cell and Gene Therapy Pricing and Access Read More
by healthadvances Posted on May 16, 2023 Winning the China Market: A Review of NRDL Inclusions Read More
by healthadvances Posted on May 12, 2023 AI is Poised to Completely Change MSK, Just Not Where You Think Read More
by healthadvances Posted on April 27, 2023 An (Unfortunately) Unoriginal Take on How to Improve MSK Care Read More
by healthadvances Posted on April 11, 2023 One-Hit Wonders: The Second Product Problem in Biotech Read More
by healthadvances Posted on April 4, 2023 Reflections from Harvard Business School’s D^3 Catalyst Women’s Health Workshop 2023 Read More
by healthadvances Posted on March 29, 2023March 29, 2023 CNS Year in Review: Introduction and Large CNS Diseases Read More
by healthadvances Posted on March 28, 2023 Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines Read More
by healthadvances Posted on March 17, 2023 AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World” Read More
by healthadvances Posted on March 9, 2023 Task Shifting in Reimagined Care Models and the Role of Technology Read More
by healthadvances Posted on March 8, 2023 AI in Healthcare: Implications at the Molecular, System, and Patient Level Read More
by healthadvances Posted on March 7, 2023 Is the Healthcare Industry Meeting the Rising Expectations of Consumers? Read More
by healthadvances Posted on February 22, 2023 The Humira Biosimilars Have Arrived! Will They Make a Difference? Read More
by healthadvances Posted on January 13, 2023 Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook Read More
by healthadvances Posted on January 4, 2023 Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals Read More
